课题基金 / 基金详情

Somatic cell mutant affecting cholesterol transport

Somatic cell mutant affecting cholesterol transport
影响胆固醇转运的体细胞突变体
批准号:
6771502
负责人:
LAURA LISCUM
金额:
$30.08万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-05-01 至 2009-04-30

项目摘要

项目成果

LAURA LISCUM的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):哺乳动物细胞严格调节其胆固醇含量和分布。在肝脏中,细胞胆固醇向内质网(ER)的移动对于其转化为胆固醇酯并随后掺入新生脂蛋白至关重要。它也是肝胆固醇代谢为胆汁酸所必需的。胆固醇转运到ER的途径和机制尚不清楚。阐明负责胆固醇运动到ER的细胞因子可能揭示高胆固醇血症的新治疗靶点。 我们已经分离出一种体细胞突变体,其质膜胆固醇向ER的运输有缺陷(3,4)。中国仓鼠卵巢(CHO)突变体3-6将新合成的胆固醇和脂蛋白衍生的胆固醇都转运到质膜,但不能将细胞表面胆固醇动员到ER用于代谢或调节稳态应答。这种表型可能是由于质膜脂质组成的变化,因为尽管3-6细胞质膜中胆固醇水平增加,但3-6细胞对阿替霉素B和在富含胆固醇的膜中形成孔的多烯抗生素具有抗性。 我们的假设是3-6基因编码一种影响质膜脂质组织的蛋白质。3-6活性的丧失改变了质膜脂质结构域的结构,使得胆固醇既潜伏于阿氏菌素B,又被阻止进入其内吞途径。本研究的目的是: 具体目的#1:鉴定当在突变体3-6细胞中表达时,纠正胆固醇转运缺陷表型的cDNA。3-6用逆转录病毒cDNA文库转染表达亲嗜性逆转录病毒受体的细胞,鉴定校正表型的cDNA。我们将确定哪一个正确的cDNA编码3-6蛋白。 具体目标#2:鉴定其表达水平被3-6突变改变的蛋白质。分别通过二维凝胶电泳和微阵列分析比较CHO与3-6蛋白质组和基因表达模式,揭示了候选3-6蛋白和被3-6突变改变的途径。两种方法的候选人都将得到验证。 具体目标#3:确定3-6诱导的细胞脂质代谢变化。我们将确定3-6突变如何改变质膜和/或ER脂质组成。将在亲本CHO细胞和突变体3-6中检查鞘脂运输。我们将研究候选3-6和抑制表型的蛋白质调节这些膜参数的机制。
英文摘要
DESCRIPTION (provided by applicant): Mammalian cells tightly regulate their cholesterol content and distribution. In the liver, the movement of cellular cholesterol to the endoplasmic reticulum (ER) is critical for its conversion to cholesteryl esters and subsequent incorporation into nascent lipoproteins. It is also essential for metabolism of hepatic cholesterol to bile acids. The route and mechanism of cholesterol transport to the ER is unknown. Elucidation of cellular factors responsible for cholesterol movement to the ER may reveal new therapeutic targets for hypercholesterolemia. We have isolated a somatic cell mutant with defective trafficking of plasma membrane cholesterol to the ER (3,4). Chinese hamster ovary (CHO) mutant 3-6 transports both newly synthesized and lipoprotein-derived cholesterol to the plasma membrane, but fails to mobilize cell surface cholesterol to the ER for metabolism or regulation of homeostatic responses. This phenotype is likely due to a change in the plasma membrane lipid composition since, despite increased levels of cholesterol in the 3-6 plasma membranes, 3-6 cells are resistant to amphotericin B, and an polyene antibiotic that forms pores in cholesterol-rich membranes. Our hypothesis is that the 3-6 gene encodes a protein that affects the lipid organization of the plasma membrane. Loss of 3-6 activity alters the plasma membrane lipid domain structure such that cholesterol is both latent to amphotericin B and prevented from entering its endocytic pathway. The Aims of this study are: Specific Aim #1: To identify cDNAs that, when expressed in mutant 3-6 cells, correct the cholesterol transport defective phenotype. 3-6 cells expressing an ecotropic retroviral receptor will be transfected with a retroviral cDNA library, cDNAs that correct the phenotype will be identified. We will determine which of the correcting cDNAs encode the 3-6 protein. Specific Aim #2: To identify proteins whose expression levels are altered by the 3-6 mutation. Comparison of CHO vs. 3-6 proteomes and gene expression patterns by two-dimensional gel electrophoresis and microarray analysis, respectively, has revealed candidate 3-6 proteins and pathways altered by the 3-6 mutation. Candidates from both approaches will be validated. Specific Aim #3: To define the 3-6 induced changes in cellular lipid metabolism. We will determine how the 3-6 mutation alters the plasma membrane and/or ER lipid compositions. Sphingolipid trafficking will be examined in parental CHO cells and mutant 3-6. We will investigate the mechanism by which candidate 3-6 and proteins that suppress the phenotype modulate these membrane parameters.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Building Diversity in Biomedical Sciences
  • 批准号:
    8656380
  • 项目类别:
  • 资助金额:
    $11.26万
  • 财政年份:
    2008
  • 负责人:
    LAURA LISCUM
  • 依托单位:
Building Diversity in Biomedical Sciences
  • 批准号:
    8507922
  • 项目类别:
  • 资助金额:
    $11.0万
  • 财政年份:
    2008
  • 负责人:
    LAURA LISCUM
  • 依托单位:
Building Diversity in Biomedical Sciences
  • 批准号:
    8253707
  • 项目类别:
  • 资助金额:
    $13.1万
  • 财政年份:
    2008
  • 负责人:
    LAURA LISCUM
  • 依托单位:
Building Diversity in Biomedical Sciences
  • 批准号:
    8058758
  • 项目类别:
  • 资助金额:
    $13.1万
  • 财政年份:
    2008
  • 负责人:
    LAURA LISCUM
  • 依托单位:
海外基金